Stellar Biotechnologies, Inc.

417 E. Hueneme Rd. PMB #170
Port Hueneme, CA 93041

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $4.07MM
First Award Date 02/01/00
Most Recent Award Date 01/01/09

Key Personnel

Last Name Name Awards Contact
Spaulding David C Spaulding 3
Oakes Frank R Oakes 6 Message

9 Awards Won

Phase 2 SBIR

Agency: National Science Foundation
Topic: 2009
Budget: 01/01/09 - 12/31/09

This Small Business Innovation Research (SBIR) Phase II project will develop methods for the control of larval settlement, metamorphosis and postlarval growth of Megathura crenulata (keyhole limpet) to support the production of commercial quantities of Keyhole Limpet Hemocyanin (KLH), a unique and medically valuable marine natural product. Unlik...

Phase 1 SBIR

Agency: National Science Foundation
Topic: 2008
Budget: 01/01/08 - 12/31/08

This Small Business Innovation Research Phase I project develops methods for the reliable control of settlement and metamorphosis of larval stages of Megathura crenulata (the giant keyhole limpet) to support the production of commercial quantities of Keyhole Limpet Hemocyanin (KLH), a unique and medically valuable marine natural product. Unlike ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-03-074
Budget: 08/01/06 - 07/31/09

The continuing goal of this project is to produce reliable and large-scale supplies of medical grade, quality-controlled Keyhole Limpet Hemocyanin (KLH) products ready for use in an expanding array of cancer vaccines, immunological uses and other biomedical applications s_jnported by the NIH and pdvate industry. With. the assistarme of funds fro...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-03-074
Budget: 08/01/05 - 07/31/06

DESCRIPTION (provided by applicant): The continuing goal of this project is to produce reliable and large-scale supplies of medical grade, quality-controlled Keyhole Limpet Hemocyanin (KLH) products ready for use in an expanding array of cancer vaccines, immunological uses and other biomedical applications supported by the NIH and private indus...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-03-074
Budget: 08/19/04 - 07/31/05

DESCRIPTION (provided by applicant): The continuing goal of this project is to produce reliable and large-scale supplies of medical grade, quality-controlled Keyhole Limpet Hemocyanin (KLH) products ready for use in an expanding array of cancer vaccines, immunological uses and other biomedical applications supported by the NIH and private indus...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/03 - 08/31/04

Development of technology is proposed for the controlled, commercial scale reproduction and rearing of Megathura crenulata, the Giant Keyhole Limpet, for production of Keyhole Limpet Hemocyanin (KLH), an active, non-specific immunotherapeutic adjuvant widely used in biomedical research and specifically in the treatment of certain cancers. The sp...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/02 - 08/31/03

Development of technology is proposed for the controlled, commercial scale reproduction and rearing of Megathura crenulata, the Giant Keyhole Limpet, for production of Keyhole Limpet Hemocyanin (KLH), an active, non-specific immunotherapeutic adjuvant widely used in biomedical research and specifically in the treatment of certain cancers. The sp...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/02

Development of technology is proposed for the controlled, commercial scale reproduction and rearing of Megathura crenulata, the Giant Keyhole Limpet, for production of Keyhole Limpet Hemocyanin (KLH), an active, non-specific immunotherapeutic adjuvant widely used in biomedical research and specifically in the treatment of certain cancers. The sp...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/00 - 07/31/01

DESCRIPTION: (Adapted from the applicant's abstract) Development of technology is proposed for controlled reproduction and rearing of juvenile Megathura crenulata, the Giant Keyhole Limpet, for use in the production of clinical grade Keyhole Limpet Hemocyanin [KLH], an active, non-specific immunot...